Haplomics, Inc.
Haplomics, Inc. is developing a genetic cure for hemophilia using state-of-the-art, gene editing techniques, using CRISPR/Cas9 mediated techniques.
- Stage Prototype Ready
- Industry Biotechnology
- Location Los Angeles, CA, US
- Currency USD
- Founded November 1995
- Employees 5
- Incorporation Type C-corp
- Website http://haplomicsinc.com
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.